Home/Filings/4/0000792977-20-000018
4//SEC Filing

Krop Julie 4

Accession 0000792977-20-000018

CIK 0000792977other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 4:46 PM ET

Size

6.7 KB

Accession

0000792977-20-000018

Insider Transaction Report

Form 4
Period: 2020-02-23
Krop Julie
SVP Clinical & Regulatory, CMO
Transactions
  • Tax Payment

    Common Stock

    2020-02-23$9.50/sh867$8,23783,032 total
  • Tax Payment

    Common Stock

    2020-02-25$8.84/sh1,155$10,21081,877 total
Footnotes (3)
  • [F1]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,501 restricted stock units on February 23, 2020.
  • [F2]Reporting person's total beneficial ownership reflects the purchase of 2,500 shares through an Employee Stock Purchase Plan on November 30, 2019.
  • [F3]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,333 restricted stock units on February 25, 2020.

Issuer

AMAG PHARMACEUTICALS, INC.

CIK 0000792977

Entity typeother

Related Parties

1
  • filerCIK 0001643127

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:46 PM ET
Size
6.7 KB